17 March 2008
ECO Animal Health Group plc
(formerly Lawrence plc)
ECO RECEIVES FURTHER REGISTRATION APPROVALS
ECO Animal Health Group plc is pleased to announce that its subsidiary Eco
Animal Health (Eco) has been granted registration approvals for Ecomectin®
Premix for pigs in Europe.
These new approvals allow Eco to market Ecomectin® Premix in twelve key European
markets estimated to be worth in the region of £8 million at manufacturer level.
Ecomectin® Premix is authorised for the treatment of adult and immature stages
of roundworms, lungworms, lice and mange mites in pigs. .
Ecomectin® Premix, which is formulated to be easily incorporated into pig feed,
is an antiparasitic treatment and provides a simple solution to the problem of
accurately treating a large numbers of pigs simultaneously.
These new approvals build upon the current European authorisations for the
Ecomectin® product portfolio, which include an injection licensed for the
treatment of pigs, cattle and sheep, a pour-on for cattle and a paste
formulation for horses.
Contacts:
ECO Animal Health Group plc Marc Loomes 020 8447
8899
Spiro Financial Anthony Spiro 020 8336 6196
Cenkos Securities plc Stephen Keys 020
7397 8926
(Nominated Adviser)
ECO Animal Health Group plc is a leader in the development, registration and
marketing of pharmaceutical products. Our products for these global growth
markets promote well-being in animals. Our financial goals are achieved through
the careful and responsible application of science to generate value for our
shareholders.
.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.